Monday, May 21, 2018
France’s L’Oreal said it had agreed to buy South Korean make-up and fashion firm Nanda, as foreign cosmetic industry leaders jostle for a slice of one of the world’s most innovative beauty markets.
Wednesday, May 2, 2018
France’s AccorHotels (ACCP.PA) has agreed to buy Movenpick Hotels & Resorts for 560 million Swiss francs ($567 million) as CEO Sebastien Bazin pushes his expansion drive into emerging markets.
Swiss-based Nestle, the world’s largest food and beverage company, will pay Starbucks Corp $7.15 billion in cash for exclusive rights to sell the U.S. chain’s packaged coffees and teas around the world, tying a premium brand to Nestle’s global distribution muscle.
Monday, April 30, 2018
Brazil-based pharmaceutical company Biolab Pharma has signed an acquisition agreement for Actavis Brasil, property of the Teva Group.
Monday, April 16, 2018
Auto components maker Key Safety Systems completed a $1.6 billion deal to acquire air-bag maker Takata Corp, whose faulty inflators triggered the auto industry’s biggest recall and have been linked to at least 22 deaths around the world.
Thursday, March 29, 2018
U.S. exchange operator CME Group is in advanced talks to buy Britain’s NEX Group for about 3.8 billion pounds ($5.4 billion) to create a cross-border trading powerhouse.
Danone has announced that it has completed the sale of 14% of its stake in Japanese probiotic drinks company Yakult for €1.3 billion
Swiss pharmaceutical firm Novartis is selling its stake in a consumer health care joint venture with GlaxoSmithKline to the British company for $13 billion.
Friday, March 23, 2018
Salesforce.com Inc said it would buy U.S. software maker MuleSoft Inc for about $5.90 billion in a cash-and-stock deal.
Wednesday, March 14, 2018
São Paulo private equity firm SouthRock Capital has signed an agreement with Starbucks Corp that gives it the right to develop and operate branches of the Seattle-based chain in Brazil
Monday, March 12, 2018
Cigna agreed to buy Express Scripts Holding for $54 billion in cash and stock, another move toward consolidation between U.S. health insurers and the companies that oversee patients’ drug benefits
Tuesday, January 9, 2018
U.S. biotech pharmaceutical firm Celgene Corp (CELG.O) said on Sunday that it had agreed to acquire Impact Biomedicines for as much as $7 billion, subject to certain milestones associated with regulatory hurdles and sales performance.